Phenglutarimide hydrochloride

For quantitative determination of phospholipase D activity and evaluation of drug effects on phospholipase D metabolism. Detection range colorimetric assay 0.

General description This substance is a primary reference substance with assigned absolute purity (considering chromatographic purity, water, residual solvents, inorganic impurities). The exact value can be found on the certificate.

InformationFabomotizole hydrochloride (Fabomotizole, CM346, CM346, Afobazol, Afobazole) exhibits anxiolytic and neuroprotective properties. Fabomotizole hydrochloride is a potentsigma1-receptoragonist with IC50 of 7.1 µM and Ki of 5.9 µM.

InformationFabomotizole hydrochloride (Fabomotizole, CM346, CM346, Afobazol, Afobazole) exhibits anxiolytic and neuroprotective properties. Fabomotizole hydrochloride is a potentsigma1-receptoragonist with IC50 of 7.1 µM and Ki of 5.9 µM.

InformationFabomotizole hydrochloride (Fabomotizole, CM346, CM346, Afobazol, Afobazole) exhibits anxiolytic and neuroprotective properties. Fabomotizole hydrochloride is a potentsigma1-receptoragonist with IC50 of 7.1 µM and Ki of 5.9 µM.

InformationFabomotizole hydrochloride (Fabomotizole, CM346, CM346, Afobazol, Afobazole) exhibits anxiolytic and neuroprotective properties. Fabomotizole hydrochloride is a potentsigma1-receptoragonist with IC50 of 7.1 µM and Ki of 5.9 µM.

InformationFabomotizole hydrochloride (Fabomotizole, CM346, CM346, Afobazol, Afobazole) exhibits anxiolytic and neuroprotective properties. Fabomotizole hydrochloride is a potentsigma1-receptoragonist with IC50 of 7.1 µM and Ki of 5.9 µM.

InformationFabomotizole hydrochloride (Fabomotizole, CM346, CM346, Afobazol, Afobazole) exhibits anxiolytic and neuroprotective properties. Fabomotizole hydrochloride is a potentsigma1-receptoragonist with IC50 of 7.1 µM and Ki of 5.9 µM.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the

InformationFmoc-​Phe-​Lys(Boc)​-​PAB (FBN33428) is a hydrolyzable linker for making ADC conjugate which is used to make hydrolyzable prodrugs for delivery of anticancer drugs to metastatic cells.

InformationFmoc-​Phe-​Lys(Boc)​-​PAB (FBN33428) is a hydrolyzable linker for making ADC conjugate which is used to make hydrolyzable prodrugs for delivery of anticancer drugs to metastatic cells.